In addition, heat shock factor-1 over-expression in ALS mice enhanced proteostasis, as shown by the increased solubility of mutant SOD1 in motor neurons and astrocytes, thus confirming that strategies that activate heat shock factor-1 are valid therapies for ALS [37]. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.